InSite Vision Inc. commences a 900 patient Phase III trial (DOUBle study)for Azasite Plus ( dexamethasone plus azithromycin)-ISV 502 and...
QLT Inc announced that it has entered into a merger agreement with InSite Vision Incorporated pursuant to which QLT will...
Sun Pharmaceutical Industries Ltd. has announced that one of its subsidiaries has entered into an agreement and plan of merger...